Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7

Vaccine. 2010 Jul 5;28(30):4777-85. doi: 10.1016/j.vaccine.2010.04.099. Epub 2010 May 14.

Abstract

Previously, we showed that the Shiga toxin type 2 (Stx2)-expressing Escherichia coli O157:H7 strain 86-24 colonized mice better than did its isogenic stx(2) negative mutant. Here, we confirmed that finding by demonstrating that Stx2 given orally to mice increased the levels of the 86-24 stx(2) mutant shed in feces. Then we assessed the impact of Stx2-neutralizing antibodies, administered passively or generated by immunization with an Stx2 toxoid, on E. coli O157:H7 colonization of mice. We found that such antibodies reduced the E. coli O157:H7 burden in infected mice and, as anticipated, also protected them from weight loss and death.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Bacterial / immunology*
  • Antibodies, Neutralizing / immunology*
  • Enzyme-Linked Immunosorbent Assay
  • Escherichia coli Infections / immunology
  • Escherichia coli Infections / microbiology*
  • Escherichia coli Infections / prevention & control*
  • Escherichia coli O157 / genetics*
  • Escherichia coli O157 / immunology*
  • Feces / chemistry
  • Female
  • Immunization, Passive
  • Mice
  • Mice, Inbred BALB C
  • Neutralization Tests
  • Rabbits
  • Shiga Toxin 2 / genetics
  • Shiga Toxin 2 / immunology*
  • Toxoids / immunology
  • Toxoids / therapeutic use
  • Vaccination
  • Weight Loss

Substances

  • Antibodies, Bacterial
  • Antibodies, Neutralizing
  • Shiga Toxin 2
  • Toxoids